In ovarian cancer, METTL3 activity has been reported to accelerate cell proliferation and migration by regulating transcription of AXL receptor tyrosine kinase (AXL, referring to the Greek term “anexelekto”, which means uncontrolled) [13, 14]. The gene discussed is AXL; the disease is ovarian cancer.